| 摘要 |
PROBLEM TO BE SOLVED: To provide a novel polyfunctional compound for pharmaceutical purposes.SOLUTION: The present invention relates to a synthetic bifunctional non-antibody compound comprising one or more effector parts and one or more binder parts, where the effector part is operationally linked to the binder part via a linker, the effector part is a ligand for at least one pathogen pattern recognition receptor (PRR), and the binder part is bonded to a marker of a tumor cell. This effector is any substance introducing, regulating or mediating the immune response of a host or being involved in the immune response. In particular, the effector includes an immune response of a congenital immune system in particular. |
